Cyclacel Pharmaceuticals (CYCC)
(Delayed Data from NSDQ)
$2.65 USD
+0.53 (25.00%)
Updated May 1, 2024 04:00 PM ET
After-Market: $2.73 +0.08 (3.02%) 6:08 PM ET
3-Hold of 5 3
F Value B Growth B Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/09/2024
Time: -- |
3/2024 | $-5.92 | 0.00% |
Earnings Summary
For their last quarter, Cyclacel Pharmaceuticals (CYCC) reported earnings of -$6.23 per share, beating the Zacks Consensus Estimate of $-6.35 per share. This reflects a positive earnings surprise of 1.89%. Look out for CYCC's next earnings release expected on May 09, 2024. For the next earning release, we expect the company to report earnings of -$5.92 per share, reflecting a year-over-year increase of 16.03%.
Earnings History
Price & Consensus
Zacks News for CYCC
Cyclacel Pharmaceuticals, Inc. (CYCC) Upgraded to Strong Buy: Here's Why
CYCC: What are Zacks experts saying now?
Zacks Private Portfolio Services